Dermata Therapeutics Inc Financial Flexibility Index
Dermata Therapeutics Inc financial flexibility index. Dermata Therapeutics Inc (DRMA) has a Financial Flexibility Index of -1.26x as of June 2026. Free cash flow of $-2.31 Million (operating CF $-2.42 Million minus capex $110.67K) represents -1% of total liabilities ($1.83 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Dermata Therapeutics Inc (2019–2025)
Financial flexibility index of Dermata Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Dermata Therapeutics Inc across 7 annual periods. Explore Dermata Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Dermata Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Dermata Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Dermata Therapeutics Inc. For the full cash flow conversion analysis, see DRMA cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4728.93x | $-7.76 Billion | $-7.76 Billion | $1.64 Million | ▼ -83473.0% |
| 2024 | -5.66x | $-11.16 Million | $-11.16 Million | $1.97 Million | ▼ -43.3% |
| 2023 | -3.95x | $-6.41 Million | $-6.41 Million | $1.62 Million | ▲ +58.8% |
| 2022 | -9.57x | $-8.83 Million | $-8.83 Million | $922.63K | ▼ -155.1% |
| 2021 | -3.75x | $-5.69 Million | $-5.69 Million | $1.52 Million | ▼ -252.5% |
| 2020 | -1.06x | $-4.03 Million | $-4.03 Million | $3.78 Million | ▲ +38.2% |
| 2019 | -1.72x | $-3.92 Million | $-3.92 Million | $2.28 Million | — |